Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 1/20 | 0.48 |
| ▸ | SPHK1 | Q9NYA1 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | TP53 | P04637 | 2/20 | 0.39 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.38 |
| ▸ | ADH1B | P00325 | 1/20 | 0.38 |
| ▸ | ADH1C | P00326 | 1/20 | 0.38 |
| ▸ | ADH1A | P07327 | 1/20 | 0.38 |
| ▸ | ADH4 | P08319 | 1/20 | 0.38 |
| ▸ | ADH7 | P40394 | 1/20 | 0.38 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.38 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.38 |
| ▸ | GMNN | O75496 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | THPO | P40225 | 1/20 | 0.38 |
| ▸ | MTOR | P42345 | 1/20 | 0.38 |
| ▸ | BLM | P54132 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8385121 | 1.00 | OPRM1 (0.48) | OPRM1SPHK1LMNATP53DNM1 | |
| SCHEMBL8385082 | 1.00 | OPRM1 (0.48) | OPRM1SPHK1LMNATP53DNM1 | |
| SCHEMBL331199 | 1.00 | OPRM1 (0.48) | OPRM1SPHK1LMNATP53DNM1 | |
| SCHEMBL924201 | 1.00 | OPRM1 (0.48) | OPRM1SPHK1LMNATP53DNM1 | |
| SCHEMBL8386214 | 1.00 | OPRM1 (0.48) | OPRM1SPHK1LMNATP53DNM1 | |
| SCHEMBL332857 | 1.00 | OPRM1 (0.48) | OPRM1SPHK1LMNATP53DNM1 | |
| SCHEMBL8383457 | 1.00 | OPRM1 (0.48) | OPRM1SPHK1LMNATP53DNM1 | |
| SCHEMBL125359 | 1.00 | OPRM1 (0.48) | OPRM1SPHK1LMNATP53DNM1 | |
| SCHEMBL17257510 | 1.00 | OPRM1 (0.48) | OPRM1SPHK1LMNATP53DNM1 | |
| SCHEMBL2266510 | 1.00 | OPRM1 (0.48) | OPRM1SPHK1LMNATP53DNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 122 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110269029-A1 | DIRECT ALCOHOL ANION FUEL CELL WITH BIOCATHODE | AKERMIN, INC. (US) | 2011-11-03 | — | — | US | claimed |
| EP-2362809-A2 | PROCESS FOR ACCELERATED CAPTURE OF CARBON DIOXIDE | Akermin, Inc. (US) | 2011-09-07 | — | — | EP | claimed |
| US-20100209968-A1 | IMMOBILIZED ENZYMES AND USES THEREOF | AKERMIN, INC. (US) | 2010-08-19 | — | — | US | claimed |
| JP-2010516017-A | — | — | 2010-05-13 | — | — | JP | claimed |
| WO-2010037109-A2 | PROCESS FOR ACCELERATED CAPTURE OF CARBON DIOXIDE | AKERMIN, INC. (US) | 2010-04-01 | — | — | WO | claimed |
| WO-2010037138-A2 | DIRECT ALCOHOL ANION FUEL CELL WITH BIOCATHODE | AKERMIN, INC. (US) | 2010-04-01 | — | — | WO | claimed |
| CN-101689638-A | immobilized enzymes and uses thereof | AKERMIN INC | 2010-03-31 | — | — | CN | claimed |
| EP-2158627-A2 | IMMOBILIZED ENZYMES AND USES THEREOF | Akermin, Inc. (US) | 2010-03-03 | — | — | EP | claimed |
| EP-2080243-A2 | BIOANODE AND BIOCATHODE STACK ASSEMBLIES | Akermin, Inc. (US) | 2009-07-22 | — | — | EP | claimed |
| WO-2008137846-A2 | IMMOBILIZED ENZYMES AND USES THEREOF | AKERMIN, INC. (US) | 2008-11-13 | — | — | WO | claimed |
| WO-2008058165-A2 | BIOANODE AND BIOCATHODE STACK ASSEMBLIES | AKERMIN, INC. (US) | 2008-05-15 | — | — | WO | claimed |
| US-4225498-A | Preparation of N-substituted oligo-imides | RHONE-POULENC INDUSTRIES (FR) | 1980-09-30 | — | — | US | claimed |
| CN-112771117-B | Method for manufacturing stretched body, plastic bottle and container | 三菱瓦斯化学株式会社 | 2023-06-02 | — | — | CN | disclosed |
| WO-2022058064-A1 | AGENT FOR DECOLORIZING KERATIN MATERIAL WHICH HAS BEEN DYED USING AN ORGANOSILICON COMPOUND AND A PIGMENT | HENKEL AG & CO. KGAA (DE) | 2022-03-24 | — | — | WO | disclosed |
| US-11077038-B2 | Cosmetic shampoos with low water content in a pouch | HENKEL AG & CO. KGAA (DE) | 2021-08-03 | — | — | US | disclosed |
| US-11077034-B2 | Care conditioner with a low water content in a pouch | HENKEL AG & CO. KGAA (DE) | 2021-08-03 | — | — | US | disclosed |
| EP-0707489-A4 | ATHEROSCLEROTIC PLAQUE SPECIFIC ANTIGENS, ANTIBODIES THERETO, AND USES THEREOF | SCOTGEN BIOPHARMACEUTICALS INC (US) | 1998-07-29 | — | — | EP | disclosed |
| EP-0707489-A1 | ATHEROSCLEROTIC PLAQUE SPECIFIC ANTIGENS, ANTIBODIES THERETO, AND USES THEREOF | Scotgen Biopharmaceuticals, Inc. (US) | 1996-04-24 | — | — | EP | disclosed |
| WO-1994025053-A1 | ATHEROSCLEROTIC PLAQUE SPECIFIC ANTIGENS, ANTIBODIES THERETO, AND USES THEREOF | SCOTGEN BIOPHARMACEUTICALS, INC. (US) | 1994-11-10 | — | — | WO | disclosed |
| US-4225498-A | Preparation of N-substituted oligo-imides | RHONE-POULENC INDUSTRIES (FR) | 1980-09-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11077038-B2 | Cosmetic shampoos with low water content in a pouch | KRT18, POLR1C, CUTA | OPRM1 4706/4885SPHK1 3593/4885LMNA 1128/4885 |
| US-11077034-B2 | Care conditioner with a low water content in a pouch | KRT18, CUTA, HACD2 | OPRM1 4733/4885SPHK1 2408/4885LMNA 1360/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.